Industry Symposium
Evolution of treatment sequencing in patients with mTNBC
Supported by Gilead
Friday, October 14, 2022 Hall C (Room M1)
08:30-09:30
Admission to this symposium is included as part of the congress registration.
| Chairperson: | Richard de Boer, Melbourne, Australia |
| Opening and introduction Richard de Boer, Melbourne, Australia |
|
| Evolution of treatment sequencing in patients with mTNBC Alistair Ring, London, UK |
|
| Case study presentations Richard de Boer, Melbourne, Australia |
|
| Discussion and questions with panelists Catherine Shannon, Brisbane, Australia Marisa Stevens, Melbourne, Australia |